DOCSLIB.ORG

S, Ro I in Bulletin LV LGHQWLILHG DV the Source of the Information. He U

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
S, Ro I in Bulletin LV LGHQWLILHG DV the Source of the Information. He U www.OTC-bulletin.com THE BUSINESS NEWSLETTER FOR THE CONSUMER HEALTHCARE INDUSTRY Bulletin Publishing Group OTC Publications Ltd 4 Poplar Road, Dorridge Solihull B93 8DB, UK Tel: +44 (0)1564 777550 Fax: +44 (0)1564 777524 E-mail: [email protected] COPYRIGHT NOTICE This publication must not be forwarded, exported, distributed or circulated by any means or in any format to persons including clients outside the direct employment of your Company. You may distribute the publication internally, but you may incorporate only insubstantial extracts, abstracts or summaries into presentations, providing OTC bulletin is identified as the source of the information. The publication/s, OTC bulletin and/or news@OTCbulletin, in PDF and/or HTML format, are supplied to you strictly under the terms and conditions of the Global Licence agreement between your Company and OTC Publications Ltd, the copyright holder of the publications. The publication/s are the intellectual property of the Publisher, OTC Publications Ltd and are protected by English copyright, trademark and other laws. Bulletin Publishing Group is a division of OTC Publications Ltd Registered Office: 4 Poplar Road, Dorridge, Solihull B93 8DB, UK. Registered in England No 2765878 OTC29-11-13p1Draft_OTC15/11/2005 p1&24 26/11/2013 16:12 Page 1 29 November 2013 COMPANY NEWS 3 PGT expandsVMS reach Endo to pay US$1.6 billion 3 for Canada’s PaladinLabs BioGaiastrikes Braziliandeal 3 withSwisse Wellness deal MerckKGaA to invest 4 in Consumer Health Celesio’s European network 5 GT Healthcareisset to expand signifi- collaboration is part of our DNA,”the spokes- moves closer Pcantly its reach in the global vitamins, person pointed out. “With so much innovation SalesofBranded Products 6 minerals and supplements (VMS) market in the healthcare market, there are manypeo- riseatStada after signing an exclusive licensing agree- ple out there doing interesting things that could Prestige Brands eyes 7 ment with Australia’sSwisse Wellness. complement our portfolio and would benefit global acquisitions Under the terms of the deal, PGT –the in- from our unique capabilities.” GNC sees growth across 8 ternational OTCjoint venture between Procter Outlining what PGT waslooking for,the allits businesssegments &Gamble and Teva –will roll out more than spokesperson said the companywas happyto KerasalNeuroCream gets 9 100 of Swisse’sVMS products in “all markets hear from companies which had a“novelOTC wider distributioninthe US across Asia, Europe and Latin America”. The product, innovative packaging solution, or tech- Valeant wantsOTC brands 10 range is already available in Australia, New nology or service” that would improve PGT’s to grow in Emerging Markets Zealand and the US. “manufacturing and go-to-market capabilities”. Perrigolines up rival 11 The move is PGT’sfirst major global deal PGT was“especially interested in the respi- to OTCNasacort since it wasestablished just overtwo years ago ratory,digestive wellness and VMS categories”, (OTC bulletin,16November 2011, page 1). the spokesperson added, butwas “open to op- GENERAL NEWS 12 PGToperates essentially in all markets outside portunitiesinmanyother self-care categories”. of North America and also develops newbrands Explaining the rationale behind the tie-up, Health Canada proposes 12 for the North American market. Teva is acting PGTand Swisse said that the deal would com- omeprazoleOTC switch as manufacturer and supplier both for the PGT bine both firms’ “core strengths and capabil- EFSA opinion giveshope 13 to botanicals business and Procter &Gamble’sNorth Amer- ities”. This would enable the rapid expansion ican OTCbusiness. of Swisse-branded VMS products into new Sanofi sues FDAtoprevent 16 releaseofNasacortdetails Aspokesperson for PGT told OTC bulletin countries, “creating anew global ‘megabrand’”. that the companywas on the look out for fur- The collaboration would benefit from “the WSMI head sees evidence 17 as keytoboosting self-care ther deals similar to the one struck with Swisse. deep consumer understanding, unrivalled mar- “PGT Healthcare is ‘open for business’ and ■ Continued on page 27 MARKETING NEWS 18 McNeiltosupportGerman 18 launchofNicorette Spray Meda canbackMidNite claims 18 CFR sees OTC synergies with Adcock Reckitt focuses on twins 19 TC synergies worth US$80 million (C59 Alejandro Weinstein, significant synergies could to highlight E45difference Omillion) are among at least US$440 mil- be unlocked by bringing Adcock’s“cost-com- Sanofi scores Cenovis tie-up 19 lion in total sales and cost synergies that CFR petitive”analgesic, digestive and cold and flu Blackmores encourages 20 Pharmaceuticals believesitwill be able to un- brands into the US$12 billion Latin American Australians to stress less lock if Adcock Ingram’sshareholders accept a OTCmarket that had grown by 12% per year ZAR12.6 billion (C919 million) binding take- on average between 2007 and 2012. FEATURES 22 overoffer for the South African company. Noting that the Chilean company’sK2con- Industrylooks for more 22 At present, shareholders representing 29.3% sumer healthcare division had generated aturn- from outsourcing of Adcock’svoting shares have givenirrevo- overofUS$82 million last year,Weinstein com- Synergies spell trouble 24 cable undertakings to back the deal, while Pru- mented: “CFR’sOTC portfolio is currently for OTC firms dential –which owns a7.5% stake–has given positioned towards higher-income consumers aletter of support. In total, CFR claims around and does not target the mid-to-lower end of REGULARS 45%ofAdcock’sshareholders have indicated the market.”Introducing CFR’sOTC brands support for the offer.But one of Adcock’smajor into South Africa, he added, would represent Events – Our regularlisting 21 shareholders, South Africa’sPublic Investment “additional upside”. People – Bootsexpands itsUKteam 27 Corporation (PIC), has voiced its opposition. Of the targetted US$440 million in total with Walgreens’executive According to CFR’schief executive officer, ■ Continued on page 8 OTC29-11-13p3-11FIN_Layout 1 26/11/2013 15:57 Page 3 COMPANY NEWS OTC DistributionAgreements Mergers&Acquisitions BioGaia strikes Endo to pay US$1.6 billion Brazilian deal for Canada’s Paladin Labs ioGaia’sprobiotic drops and tablets will Bsoon be available in Brazil, after it signed ndo Health Solutions has agreed to pay adistribution agreement with local pharma- EUS$1.6 billion (C1.2 billion) to acquire ceutical companyAché. Paladin Labs, the Canadian speciality pharma- Underthe terms of the deal, Aché has the ceuticals firm that holds acontrolling 61.5% exclusive rights to sell in Brazil BioGaia’sPro- stakeinSouth Africa’sLitha Healthcare. Tectis baby drops and ProTectis tablets con- The CA$77.00 (C55.16) per share offer –to taining theprobiotic Lactobacillusreuteri. be conducted through anewly-formed Irish Both thedrops and tablets would be co- holding company–represents a20% premium branded, the Swedish probiotic specialist point- overPaladin’sclosing share price on 4Novem- ed out, with thelaunch planned for 2014. ber of CA$63.91. Commenting on the agreement,Peter Roths- “Paladin’sprovenCanadian franchise, robust child, BioGaia’spresident, said he was“con- near-term pipeline and emerging markets busi- AcquiringPaladin Labs will give Endo arange of OTC brands, including theTempra analgesics line vinced” that Brazil would become one of the ness complement Endo’sUSstrengths,”the US firm’s“most important markets within the not companyinsisted. uct; Plan Bemergencycontraceptive;Tem- toodistant future”. Highlighting the Canadian firm’s“proven pra paediatricpainkiller range; VagiSense OTC Earlierthis year,BioGaia announced it track record of acquiring and in-licensing inno- vaginal infection screening test; and Zinco- would be devoting time and resources to find- vative newproducts and developing internation- faxnappy-rash line. ing distributors in the so-called BRIC countries al growth platforms”, Endo’spresident and Ayear ago, Paladin snapped up the exclusive of Brazil, Russia, India and China (OTC bul- chief executive officer,RajivDeSilva, said the rights to sell DynamiclearAustralia’s natural letin,10May 2013, page 10). deal would “accelerate Endo’stransformation OTCtopical cold-sore treatment Dynamiclear In September,Rothschild revealed that this from an integrated health solutionscompanyto Rapid in Canada for an undisclosed sum (OTC strategywas “starting to pay off”, following atop-tier global specialityhealthcare leader”. bulletin,26October 2012, page 3). adistribution deal with Chinese firm Beijing Under the terms of the stock-led transaction, The companyisalso awaiting approvalto Keyuan Xinhai Pharmaceutical (OTC bulletin, Paladin –which owns acontrolling stakein launch the Travelan OTCproduct for prevent- 13 September 2013,page 7). Mexico’sLaboratorios Paladin –will continue ing travellers’ diarrhoea in its home market. OTC to be aseparate operating companyunder its Paladin acquired exclusive rights to Travelan in current management team, led by chairman Canada, Latin America and Sub-Saharan Africa IN BRIEF and founder Jonathan Ross Goodman. The from Australia’sImmuron in November 2011 firm’sCanadian operations will continue under (OTC bulletin,30November 2011, page 7). ■ HEALTH IMPACT has signed adeal to the Paladin Labs name. Paladin reported second-quarter 2013 sales distribute anumber of its skincare and food Endo expects to realise US$75 million in up by 41% to CA$52.3 million. Earnings be- supplement products in Thailand through the annual post-tax operational and
Load more

Recommended publications
  • Brambles Appoints Elizabeth Fagan As a Non-Executive Director
    Brambles Limited ABN 89 118 896 021 Level 10 Angel Place, 123 Pitt Street Sydney NSW 2000 Australia GPO Box 4173 Sydney NSW 2001 Tel +61 2 9256 5222 Fax +61 2 9256 5299 www.brambles.com 2 May 2018 The Manager-Listings Australian Securities Exchange Limited Exchange Centre 20 Bridge Street SYDNEY NSW 2000 Via electronic lodgement Dear Sir / Madam Brambles appoints Managing Director of Boots UK & Ireland as a Non- Executive Director I attach an announcement relating to the above. Yours faithfully Brambles Limited Robert Gerrard Company Secretary RNG 00094498 2 May 2018 ASX & Media Release Brambles appoints Managing Director of Boots UK & Ireland as a Non-Executive Director Brambles Limited is pleased to announce the appointment of Elizabeth Fagan as a Non-Executive Director, effective 1 June 2018. Elizabeth Fagan has extensive experience in the international retail sector. She is currently Senior Vice President and Managing Director of Boots, leading all Boots businesses across the UK and the Republic of Ireland. She will step down from this role to become Non-Executive Chairman of Boots UK & Ireland on 1 September 2018. Elizabeth has held a number of senior executive roles, previously as Senior Vice President, Managing Director, International Retail for Walgreens Boots Alliance, from the Company’s creation in December 2014. During this time she was responsible for the development of the Company’s pharmacy-led health and beauty retail businesses in Latin America, Asia and Europe (outside of UK and Republic of Ireland). Prior to this, she was Marketing Director of Boots and Managing Director of Boots Opticians, and had previously worked for Boots as Group Buyer more than 25 years ago.
    [Show full text]
  • Lep-Chairs-Whos-Who-2019.Pdf
    Stewart Towe CBE DL Andrew Smith Black Country LEP Buckinghamshire LEP Stewart Towe CBE DL, Chairman and Andrew always wanted to work in the film Managing Director Hadley Industries PLC industry, then after being a civil servant, since 2006. He trained as an Accountant having a stint in politics, starting up his own with the Birmingham firm of Farmiloe & business and training to be a scuba diving Co. instructor, his dream came true and he went to work for Pinewood in 2008. Stewart moved to Hadley as Group Accountant in 1976 and appointed to Main Andrew joined Pinewood in June 2008 as Board in 1978 responsible for commercial Group Director Corporate Affairs. Appointed and financial development. Completed Company Secretary in December 2010 and the buy-out of the business in appointed to the Board in May 2012. Prior to 2006. Hadley has grown from £1m turnover in the 1970s to over £125m in this, Andrew was Managing Partner of The 2016. Hadley has manufacturing plants in UK, Holland, Turkey, Middle East Policy Partnership. Member of the Film Skills and the Far East and licensees throughout the world. Council, the British Film Commission Advisory Board, the International eGames Committee and Associate member of BAFTA. Non-Executive Director Appointed as Business in the Community’s Regional Ambassador for the of Bucks Business First Ltd and Chairman of the Buckinghamshire Thames West Midlands by HRH The Prince of Wales in June 2007. Valley Local Enterprise Partnership. High Sheriff of the West Midlands 2012. He is passionate about allowing everybody opportunity, especially the long- Chair - Business in the Community, West Midlands 2009 - 2014.
    [Show full text]
  • Mediacom Recaptures Boots UK Media After WPP's Walgreens
    NEWS MediaCom recaptures Boots UK media after WPP’s Walgreens win CLIENTS MEDIA NEW BUSINESS 21 APR 2017 Boots has appointed MediaCom as its UK media planning and buying agency. As part of Team W, MediaCom UK will be responsible for helping Boots drive its retail presence in the UK and the Republic of Ireland. The appointment follows the decision by US parent company Walgreens Boots Alliance to move all of its global communications to WPP agencies to further strengthen integration. As part of Team W – a bespoke WPP team covering traditional and digital advertising, media investment management, promotion & relationship marketing, public affairs, media relations and communications, MediaCom UK will be responsible for helping Boots continue to drive its brand and retail presence in the UK and ROI. Hub office locations for ‘Team W’ have been set up in Chicago, London and New York to support Walgreens Boots Alliance and businesses including Walgreens, Boots and Alliance Healthcare businesses. Elizabeth Fagan, Managing Director Boots UK & ROI comments: “We’re pleased to confirm that, as part of the new Walgreens Boots Alliance partnership with WPP, Boots UK will begin working with MediaCom as media agency. I would like to personally thank the team at OMD, our incumbent agency, with whom myself, and Boots have had a strong collaborative partnership over the past ten years, and we look forward to a similarly strong relationship with MediaCom in the future.” Josh Krichefski, CEO, MediaCom UK concludes: “We are really excited to be working with Boots in this new integrated model. Boots is one of the UK’s most iconic and well-loved brands with a fantastic heritage and a fascinating portfolio.
    [Show full text]
  • Walgreens Boots Alliance Announced Changes to Senior Management Team for Next Phase of Evolution
    June 9, 2016 Walgreens Boots Alliance Announced Changes to Senior Management Team for Next Phase of Evolution DEERFIELD, Ill.--(BUSINESS WIRE)-- Walgreens Boots Alliance today announced changes to its senior management roles and responsibilities as part of the next phase of evolution. This follows the successful integration of Walgreens and Alliance Boots to create Walgreens Boots Alliance, Inc. (Nasdaq: WBA). In order to provide even greater focus and collaboration and further streamline the management of the Company's global operations, Alex Gourlay, Executive Vice President of Walgreens Boots Alliance and President of Walgreens, and Ornella Barra, Executive Vice President of Walgreens Boots Alliance and President and Chief Executive of Global Wholesale and International Retail, have been appointed to the role of Co-Chief Operating Officers. In his new role, Gourlay will oversee Walgreens and Boots. In addition to her current responsibilities, Barra will supervise Global Brands, Human Resources and other business services. As a result, Ken Murphy, who becomes Executive Vice President of Walgreens Boots Alliance and Chief Commercial Officer and President of Global Brands, and Kathleen Wilson-Thompson, Executive Vice President and Global Chief Human Resources Officer, will report to her. Separately, Simon Roberts, Executive Vice President of Walgreens Boots Alliance and President of Boots, has decided at this time to pursue new opportunities and will leave the Company in July 2016. Elizabeth Fagan, currently Senior Vice President and MD International Retail, is appointed as Senior Vice President and Managing Director of Boots. "As we continue to work together to find simpler and more effective ways to manage our Company, I believe this is the right structure at the right time," said Jim Skinner, Walgreens Boots Alliance Executive Chairman.
    [Show full text]
  • 2016 Retail Year in Review a Look Back at Key Themes Across Channels Kantar Retail Research Team January 2017 Copyright © 2017 Kantar Retail
    2016 Retail Year in Review A Look Back at Key Themes Across Channels Kantar Retail Research Team January 2017 Copyright © 2017 Kantar Retail. All Rights Reserved. 501 Boylston St., Suite 6101, Boston, MA 02116 T: +1 (617) 912 2828 [email protected] No part of this material may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photography, recording, or any information storage and retrieval system now known or to be invented, without the express written permission of Kantar Retail. The printing of any copies for backup is also strictly prohibited. Disclaimers The analyses and conclusions presented in this seminar represent the opinions of Kantar Retail. The views expressed do not necessarily reflect the views of the management of the retailer(s) under discussion. This seminar is not endorsed or otherwise supported by the management of any of the companies covered during the course of the workshop or within the following slides. 2 2016 in Review: Kantar Retail’s Top 5 Takeaways A strong year cultivates greater systemic changes in the industry 1. Strong macroeconomic indicators: The macroeconomic environment was favorable to the retail industry for most of 2016. Dropping unemployment, rising wages, and less disruption than anticipated in the wake of the U.S. presidential election all contributed to broad-based dollar growth across channels. 2. Health and wellness takes center stage: Competition for share of shoppers’ well-being was a key storyline throughout the year. Whether in the form of healthier snacking options at discounters, a greater emphasis on fresh items at supercenters, or more visible sustainability at clubs, the health and wellness trend spanned multiple channels and retailers.
    [Show full text]
  • Walgreens Boots Alliance Appoints Sebastian James As Senior Vice President and President and Managing Director of Boots
    January 19, 2018 Walgreens Boots Alliance Appoints Sebastian James as Senior Vice President and President and Managing Director of Boots DEERFIELD, Ill.--(BUSINESS WIRE)-- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of Sebastian James as Senior Vice President and President and Managing Director of Boots. He also will be contributing to the Group with involvement in a number of key areas, joining the company in the summer of 2018 and taking up his new role at the beginning of the new fiscal year on 1 September. He will report to Alex Gourlay, Co-Chief Operating Officer for Walgreens Boots Alliance. James joins from Dixons Carphone plc (LSE: DC), Europe's leading specialist electrical and telecommunications retailer and services company, employing over 42,000 people in nine countries, where he is currently Group Chief Executive since 2014, having been Chief Executive of Dixon Retail since 2012. Previously, he was Chief Executive Officer of Synergy Insurance Services and Silverscreen Holdings, having started his career in management consulting with The Boston Consulting Group and Bain & Company. Elizabeth Fagan, who has led Boots since June 2016, will continue working with the Company and will take on the newly created role of Non-Executive Chairman of Boots in the new fiscal year. Gourlay said: "We are delighted that Sebastian will join our Company at an equally exciting and challenging time for the retail environment in the UK and for the future development of Boots, a brand synonymous with pharmacy and care. We are sure his deep retail expertise will drive significant progress and innovation at Boots for the benefit all our stakeholders.
    [Show full text]